| Name | Title | Contact Details |
|---|
Almost Family is a leading provider of home health nursing, rehabilitation and personal care services. We are a family of companies with names you can trust. For over thirty years, we have been providing skilled compassionate home health care in our local communities. We bring our expertise into the home - the ideal setting to promote healing, comfort and support to those facing the challenges of aging. Our Senior Advocacy philosophy addresses these challenges in a revolutionary new way. Our clinical team looks beyond the obvious needs of the patient to become advocates in all dimensions of physical, mental and emotional well-being. Our goal is to promote independence, allowing seniors to age in place for as long as possible.
MDI Medical is a Norcross, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
TigerConnect is healthcare`s most widely adopted communication platform – uniquely modernizing care collaboration among doctors, nurses, patients, and care teams. TigerConnect is the only solution that combines a consumer-like user experience for text, video, and voice communication with the serious security, privacy, and clinical workflow requirements that today`s healthcare organizations demand. TigerConnect accelerates productivity, reduces costs, and improves patient outcomes. Trusted by more than 5,000 healthcare organizations, TigerConnect maintains 99.99% verifiable uptime and processes more than 10 million messages each day.
intraFUSION is a Houston, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Glytec is the insulin management software company for healthcare providers focused on improving the quality and cost of care. Its FDA-cleared titration software and proprietary algorithms power the only solution capable of delivering personalized diabetes treatment recommendations across the continuum of care, from hospital to home. With ongoing support from its team of doctors, nurses and technologists headquartered outside of Boston, Glytec improves outcomes and controls costs for the large population of patients requiring insulin treatment – including those with and without a diagnosis of diabetes.